Effect on mode of death of heart failure treatment started with bisoprolol followed by Enalapril, compared to the opposite order: results of the randomized CIBIS III trial.
Identifieur interne : 006168 ( Main/Exploration ); précédent : 006167; suivant : 006169Effect on mode of death of heart failure treatment started with bisoprolol followed by Enalapril, compared to the opposite order: results of the randomized CIBIS III trial.
Auteurs : Henry Krum [Suède] ; Dirk J. Van Veldhuisen ; Christian Funck-Brentano ; Emilio Vanoli ; Bernard Silke ; Erland Erdmann ; Ferenc Follath ; Piotr Ponikowski ; Michael Goulder ; Wilfried Meyer ; Philippe Lechat ; Ronnie WillenheimerSource :
- Cardiovascular therapeutics [ 1755-5922 ] ; 2011.
Descripteurs français
- KwdFr :
- Antagonistes bêta-adrénergiques (administration et posologie), Association de médicaments, Bisoprolol (administration et posologie), Défaillance cardiaque (mortalité), Défaillance cardiaque (traitement médicamenteux), Femelle, Hospitalisation, Humains, Inhibiteurs de l'enzyme de conversion de l'angiotensine (administration et posologie), Maladie chronique, Mort subite cardiaque (), Mâle, Sujet âgé, Énalapril (administration et posologie).
- MESH :
- administration et posologie : Antagonistes bêta-adrénergiques, Bisoprolol, Inhibiteurs de l'enzyme de conversion de l'angiotensine, Énalapril.
- mortalité : Défaillance cardiaque.
- traitement médicamenteux : Défaillance cardiaque.
- Association de médicaments, Femelle, Hospitalisation, Humains, Maladie chronique, Mort subite cardiaque, Mâle, Sujet âgé.
English descriptors
- KwdEn :
- Adrenergic beta-Antagonists (administration & dosage), Aged, Angiotensin-Converting Enzyme Inhibitors (administration & dosage), Bisoprolol (administration & dosage), Chronic Disease, Death, Sudden, Cardiac (prevention & control), Drug Therapy, Combination, Enalapril (administration & dosage), Female, Heart Failure (drug therapy), Heart Failure (mortality), Hospitalization, Humans, Male.
- MESH :
- chemical , administration & dosage : Adrenergic beta-Antagonists, Angiotensin-Converting Enzyme Inhibitors, Bisoprolol, Enalapril.
- drug therapy : Heart Failure.
- mortality : Heart Failure.
- prevention & control : Death, Sudden, Cardiac.
- Aged, Chronic Disease, Drug Therapy, Combination, Female, Hospitalization, Humans, Male.
Abstract
Mode of death in chronic heart failure (CHF) may be of relevance to choice of therapy for this condition. Sudden death is particularly common in patients with early and/or mild/moderate CHF. β-Blockade may provide better protection against sudden death than ACE inhibition (ACEI) in this setting.
DOI: 10.1111/j.1755-5922.2010.00185.x
PubMed: 20528880
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003B99
- to stream PubMed, to step Curation: 003A54
- to stream PubMed, to step Checkpoint: 003A54
- to stream Ncbi, to step Merge: 000801
- to stream Ncbi, to step Curation: 000801
- to stream Ncbi, to step Checkpoint: 000801
- to stream Main, to step Merge: 006529
- to stream Main, to step Curation: 006168
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effect on mode of death of heart failure treatment started with bisoprolol followed by Enalapril, compared to the opposite order: results of the randomized CIBIS III trial.</title><author><name sortKey="Krum, Henry" sort="Krum, Henry" uniqKey="Krum H" first="Henry" last="Krum">Henry Krum</name><affiliation wicri:level="1"><nlm:affiliation>Departments of Epidemiology and Preventive Medicine and Medicine, Monash University, Alfred Hospital, Melbourne, Australia Thoraxcenter, Department of Cardiology, University Hospital Groningen, The Netherlands UPMC - AP-HP - INSERM CIC9304, Department of Pharmacology, Pitié-Salpêtrière Hospital, Paris, France Department of Cardiology, University of Pavia and Policlinico di Monza, Italy Department of Pharmacology & Therapeutics, Trinity Centre, St James' Hospital, Dublin, Ireland Medizinische Klinik III, University of Cologne, Germany Medicine A, University Hospital Zürich, Switzerland Department of Heart Diseases, Medical University, Wroclaw, Poland Worldwide Clinical Trials, Nottingham, UK Merck KGaA, Darmstadt, Germany Service de Pharmacologie, Hopital Pitié-Salpetriere, Paris, France Lund University and Heart Health Group, Malmö, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Departments of Epidemiology and Preventive Medicine and Medicine, Monash University, Alfred Hospital, Melbourne, Australia Thoraxcenter, Department of Cardiology, University Hospital Groningen, The Netherlands UPMC - AP-HP - INSERM CIC9304, Department of Pharmacology, Pitié-Salpêtrière Hospital, Paris, France Department of Cardiology, University of Pavia and Policlinico di Monza, Italy Department of Pharmacology & Therapeutics, Trinity Centre, St James' Hospital, Dublin, Ireland Medizinische Klinik III, University of Cologne, Germany Medicine A, University Hospital Zürich, Switzerland Department of Heart Diseases, Medical University, Wroclaw, Poland Worldwide Clinical Trials, Nottingham, UK Merck KGaA, Darmstadt, Germany Service de Pharmacologie, Hopital Pitié-Salpetriere, Paris, France Lund University and Heart Health Group, Malmö</wicri:regionArea><wicri:noRegion>Malmö</wicri:noRegion></affiliation></author><author><name sortKey="Van Veldhuisen, Dirk J" sort="Van Veldhuisen, Dirk J" uniqKey="Van Veldhuisen D" first="Dirk J" last="Van Veldhuisen">Dirk J. Van Veldhuisen</name></author><author><name sortKey="Funck Brentano, Christian" sort="Funck Brentano, Christian" uniqKey="Funck Brentano C" first="Christian" last="Funck-Brentano">Christian Funck-Brentano</name></author><author><name sortKey="Vanoli, Emilio" sort="Vanoli, Emilio" uniqKey="Vanoli E" first="Emilio" last="Vanoli">Emilio Vanoli</name></author><author><name sortKey="Silke, Bernard" sort="Silke, Bernard" uniqKey="Silke B" first="Bernard" last="Silke">Bernard Silke</name></author><author><name sortKey="Erdmann, Erland" sort="Erdmann, Erland" uniqKey="Erdmann E" first="Erland" last="Erdmann">Erland Erdmann</name></author><author><name sortKey="Follath, Ferenc" sort="Follath, Ferenc" uniqKey="Follath F" first="Ferenc" last="Follath">Ferenc Follath</name></author><author><name sortKey="Ponikowski, Piotr" sort="Ponikowski, Piotr" uniqKey="Ponikowski P" first="Piotr" last="Ponikowski">Piotr Ponikowski</name></author><author><name sortKey="Goulder, Michael" sort="Goulder, Michael" uniqKey="Goulder M" first="Michael" last="Goulder">Michael Goulder</name></author><author><name sortKey="Meyer, Wilfried" sort="Meyer, Wilfried" uniqKey="Meyer W" first="Wilfried" last="Meyer">Wilfried Meyer</name></author><author><name sortKey="Lechat, Philippe" sort="Lechat, Philippe" uniqKey="Lechat P" first="Philippe" last="Lechat">Philippe Lechat</name></author><author><name sortKey="Willenheimer, Ronnie" sort="Willenheimer, Ronnie" uniqKey="Willenheimer R" first="Ronnie" last="Willenheimer">Ronnie Willenheimer</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:20528880</idno><idno type="pmid">20528880</idno><idno type="doi">10.1111/j.1755-5922.2010.00185.x</idno><idno type="wicri:Area/PubMed/Corpus">003B99</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003B99</idno><idno type="wicri:Area/PubMed/Curation">003A54</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003A54</idno><idno type="wicri:Area/PubMed/Checkpoint">003A54</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003A54</idno><idno type="wicri:Area/Ncbi/Merge">000801</idno><idno type="wicri:Area/Ncbi/Curation">000801</idno><idno type="wicri:Area/Ncbi/Checkpoint">000801</idno><idno type="wicri:Area/Main/Merge">006529</idno><idno type="wicri:Area/Main/Curation">006168</idno><idno type="wicri:Area/Main/Exploration">006168</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Effect on mode of death of heart failure treatment started with bisoprolol followed by Enalapril, compared to the opposite order: results of the randomized CIBIS III trial.</title><author><name sortKey="Krum, Henry" sort="Krum, Henry" uniqKey="Krum H" first="Henry" last="Krum">Henry Krum</name><affiliation wicri:level="1"><nlm:affiliation>Departments of Epidemiology and Preventive Medicine and Medicine, Monash University, Alfred Hospital, Melbourne, Australia Thoraxcenter, Department of Cardiology, University Hospital Groningen, The Netherlands UPMC - AP-HP - INSERM CIC9304, Department of Pharmacology, Pitié-Salpêtrière Hospital, Paris, France Department of Cardiology, University of Pavia and Policlinico di Monza, Italy Department of Pharmacology & Therapeutics, Trinity Centre, St James' Hospital, Dublin, Ireland Medizinische Klinik III, University of Cologne, Germany Medicine A, University Hospital Zürich, Switzerland Department of Heart Diseases, Medical University, Wroclaw, Poland Worldwide Clinical Trials, Nottingham, UK Merck KGaA, Darmstadt, Germany Service de Pharmacologie, Hopital Pitié-Salpetriere, Paris, France Lund University and Heart Health Group, Malmö, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Departments of Epidemiology and Preventive Medicine and Medicine, Monash University, Alfred Hospital, Melbourne, Australia Thoraxcenter, Department of Cardiology, University Hospital Groningen, The Netherlands UPMC - AP-HP - INSERM CIC9304, Department of Pharmacology, Pitié-Salpêtrière Hospital, Paris, France Department of Cardiology, University of Pavia and Policlinico di Monza, Italy Department of Pharmacology & Therapeutics, Trinity Centre, St James' Hospital, Dublin, Ireland Medizinische Klinik III, University of Cologne, Germany Medicine A, University Hospital Zürich, Switzerland Department of Heart Diseases, Medical University, Wroclaw, Poland Worldwide Clinical Trials, Nottingham, UK Merck KGaA, Darmstadt, Germany Service de Pharmacologie, Hopital Pitié-Salpetriere, Paris, France Lund University and Heart Health Group, Malmö</wicri:regionArea><wicri:noRegion>Malmö</wicri:noRegion></affiliation></author><author><name sortKey="Van Veldhuisen, Dirk J" sort="Van Veldhuisen, Dirk J" uniqKey="Van Veldhuisen D" first="Dirk J" last="Van Veldhuisen">Dirk J. Van Veldhuisen</name></author><author><name sortKey="Funck Brentano, Christian" sort="Funck Brentano, Christian" uniqKey="Funck Brentano C" first="Christian" last="Funck-Brentano">Christian Funck-Brentano</name></author><author><name sortKey="Vanoli, Emilio" sort="Vanoli, Emilio" uniqKey="Vanoli E" first="Emilio" last="Vanoli">Emilio Vanoli</name></author><author><name sortKey="Silke, Bernard" sort="Silke, Bernard" uniqKey="Silke B" first="Bernard" last="Silke">Bernard Silke</name></author><author><name sortKey="Erdmann, Erland" sort="Erdmann, Erland" uniqKey="Erdmann E" first="Erland" last="Erdmann">Erland Erdmann</name></author><author><name sortKey="Follath, Ferenc" sort="Follath, Ferenc" uniqKey="Follath F" first="Ferenc" last="Follath">Ferenc Follath</name></author><author><name sortKey="Ponikowski, Piotr" sort="Ponikowski, Piotr" uniqKey="Ponikowski P" first="Piotr" last="Ponikowski">Piotr Ponikowski</name></author><author><name sortKey="Goulder, Michael" sort="Goulder, Michael" uniqKey="Goulder M" first="Michael" last="Goulder">Michael Goulder</name></author><author><name sortKey="Meyer, Wilfried" sort="Meyer, Wilfried" uniqKey="Meyer W" first="Wilfried" last="Meyer">Wilfried Meyer</name></author><author><name sortKey="Lechat, Philippe" sort="Lechat, Philippe" uniqKey="Lechat P" first="Philippe" last="Lechat">Philippe Lechat</name></author><author><name sortKey="Willenheimer, Ronnie" sort="Willenheimer, Ronnie" uniqKey="Willenheimer R" first="Ronnie" last="Willenheimer">Ronnie Willenheimer</name></author></analytic><series><title level="j">Cardiovascular therapeutics</title><idno type="eISSN">1755-5922</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adrenergic beta-Antagonists (administration & dosage)</term><term>Aged</term><term>Angiotensin-Converting Enzyme Inhibitors (administration & dosage)</term><term>Bisoprolol (administration & dosage)</term><term>Chronic Disease</term><term>Death, Sudden, Cardiac (prevention & control)</term><term>Drug Therapy, Combination</term><term>Enalapril (administration & dosage)</term><term>Female</term><term>Heart Failure (drug therapy)</term><term>Heart Failure (mortality)</term><term>Hospitalization</term><term>Humans</term><term>Male</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antagonistes bêta-adrénergiques (administration et posologie)</term><term>Association de médicaments</term><term>Bisoprolol (administration et posologie)</term><term>Défaillance cardiaque (mortalité)</term><term>Défaillance cardiaque (traitement médicamenteux)</term><term>Femelle</term><term>Hospitalisation</term><term>Humains</term><term>Inhibiteurs de l'enzyme de conversion de l'angiotensine (administration et posologie)</term><term>Maladie chronique</term><term>Mort subite cardiaque ()</term><term>Mâle</term><term>Sujet âgé</term><term>Énalapril (administration et posologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Adrenergic beta-Antagonists</term><term>Angiotensin-Converting Enzyme Inhibitors</term><term>Bisoprolol</term><term>Enalapril</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antagonistes bêta-adrénergiques</term><term>Bisoprolol</term><term>Inhibiteurs de l'enzyme de conversion de l'angiotensine</term><term>Énalapril</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Heart Failure</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Heart Failure</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Défaillance cardiaque</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Death, Sudden, Cardiac</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Défaillance cardiaque</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Chronic Disease</term><term>Drug Therapy, Combination</term><term>Female</term><term>Hospitalization</term><term>Humans</term><term>Male</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Association de médicaments</term><term>Femelle</term><term>Hospitalisation</term><term>Humains</term><term>Maladie chronique</term><term>Mort subite cardiaque</term><term>Mâle</term><term>Sujet âgé</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Mode of death in chronic heart failure (CHF) may be of relevance to choice of therapy for this condition. Sudden death is particularly common in patients with early and/or mild/moderate CHF. β-Blockade may provide better protection against sudden death than ACE inhibition (ACEI) in this setting.</div></front></TEI><affiliations><list><country><li>Suède</li></country></list><tree><noCountry><name sortKey="Erdmann, Erland" sort="Erdmann, Erland" uniqKey="Erdmann E" first="Erland" last="Erdmann">Erland Erdmann</name><name sortKey="Follath, Ferenc" sort="Follath, Ferenc" uniqKey="Follath F" first="Ferenc" last="Follath">Ferenc Follath</name><name sortKey="Funck Brentano, Christian" sort="Funck Brentano, Christian" uniqKey="Funck Brentano C" first="Christian" last="Funck-Brentano">Christian Funck-Brentano</name><name sortKey="Goulder, Michael" sort="Goulder, Michael" uniqKey="Goulder M" first="Michael" last="Goulder">Michael Goulder</name><name sortKey="Lechat, Philippe" sort="Lechat, Philippe" uniqKey="Lechat P" first="Philippe" last="Lechat">Philippe Lechat</name><name sortKey="Meyer, Wilfried" sort="Meyer, Wilfried" uniqKey="Meyer W" first="Wilfried" last="Meyer">Wilfried Meyer</name><name sortKey="Ponikowski, Piotr" sort="Ponikowski, Piotr" uniqKey="Ponikowski P" first="Piotr" last="Ponikowski">Piotr Ponikowski</name><name sortKey="Silke, Bernard" sort="Silke, Bernard" uniqKey="Silke B" first="Bernard" last="Silke">Bernard Silke</name><name sortKey="Van Veldhuisen, Dirk J" sort="Van Veldhuisen, Dirk J" uniqKey="Van Veldhuisen D" first="Dirk J" last="Van Veldhuisen">Dirk J. Van Veldhuisen</name><name sortKey="Vanoli, Emilio" sort="Vanoli, Emilio" uniqKey="Vanoli E" first="Emilio" last="Vanoli">Emilio Vanoli</name><name sortKey="Willenheimer, Ronnie" sort="Willenheimer, Ronnie" uniqKey="Willenheimer R" first="Ronnie" last="Willenheimer">Ronnie Willenheimer</name></noCountry><country name="Suède"><noRegion><name sortKey="Krum, Henry" sort="Krum, Henry" uniqKey="Krum H" first="Henry" last="Krum">Henry Krum</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006168 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006168 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:20528880
|texte= Effect on mode of death of heart failure treatment started with bisoprolol followed by Enalapril, compared to the opposite order: results of the randomized CIBIS III trial.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:20528880" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |